Histiocytic sarcoma arising from thyroid gland with BRAF V600E mutation

被引：1
|
作者：
Ge, Rong [1 ]
Chang, Yuqing [2 ]
Gan, Yongli [1 ]
Zhu, Haidong [3 ]
Liu, Chuangfeng [1 ]
机构：
[1] Ningbo Diagnost Pathol Ctr, Dept Diag, Ningbo, Peoples R China
[2] Shibei Hosp, Dept Pathol, Shanghai, Peoples R China
[3] Lihuili Hosp, Dept Radiol, Ningbo Med Ctr, Ningbo, Peoples R China
来源：
PATHOLOGY | 2020年 / 52卷 / 05期
关键词：
D O I：
10.1016/j.pathol.2020.04.012
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
[No abstract available]
引用
收藏
页码：603 / 605
页数：3
相关论文
共 50 条
  • [31] A BRAF V600E Mutation in RET-Negative Medullary Thyroid Cancer
    Robbins, Richard J.
    Thomas, Jessica S.
    Osuna, Patricia Mejia
    Shakil, Jawairia
    CASE REPORTS IN ENDOCRINOLOGY, 2020, 2020
  • [32] Clinical significance of BRAF V600E mutation in 154 patients with thyroid nodules
    Yu, Lingying
    Ma, Lizhen
    Tu, Qiaofeng
    Zhang, Yi
    Chen, Yueming
    Yu, Daojun
    Yang, Shaoyu
    ONCOLOGY LETTERS, 2015, 9 (06) : 2633 - 2638
  • [33] Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules
    不详
    CANCER CYTOPATHOLOGY, 2005, 105 (05) : 425 - 426
  • [34] Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer
    Xing, Mingzhao
    Alzahrani, Ali S.
    Carson, Kathryn A.
    Shong, Young Kee
    Kim, Tae Yong
    Viola, David
    Elisei, Rossella
    Bendlova, Bela
    Yip, Linwah
    Mian, Caterina
    Vianello, Federica
    Tuttle, R. Michael
    Robenshtok, Eyal
    Fagin, James A.
    Puxeddu, Efisio
    Fugazzola, Laura
    Czarniecka, Agnieszka
    Jarzab, Barbara
    O'Neill, Christine J.
    Sywak, Mark S.
    Lam, Alfred K.
    Riesco-Eizaguirre, Garcilaso
    Santisteban, Pilar
    Nakayama, Hirotaka
    Clifton-Bligh, Roderick
    Tallini, Giovanni
    Holt, Elizabeth H.
    Sykorova, Vlasta
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (01) : 42 - U79
  • [35] Investigation of V600E BRAF mutation in papillary thyroid carcinoma in the Polish population
    Brzezianska, Ewa
    Pastuszak-Lewandoska, Dorota
    Wojciechowska, Katarzyna
    Migdalska-Sek, Monika
    Cyniak-Magierska, Anna
    Nawrot, Ewa
    Lewinski, Andrzej
    NEUROENDOCRINOLOGY LETTERS, 2007, 28 (04) : 351 - 359
  • [36] BRAF V600E mutation in prognostication of papillary thyroid cancer (PTC) recurrence
    Czarniecka, Agnieszka
    Oczko-Wojciechowska, Malgorzata
    Barczynski, Marcin
    GLAND SURGERY, 2016, 5 (05) : 495 - 505
  • [37] Lack of MAPK activation in papillary thyroid carcinoma with BRAF V600E mutation
    Zuo, Hui
    Nakamura, Yasushi
    Yasuoka, Hironao
    Nakamura, Misa
    Mori, Ichiro
    Miyauchi, Akira
    Kakudo, Kennichi
    CANCER RESEARCH, 2006, 66 (08)
  • [38] Immunohistochemical detection of BRAF V600E mutation status in anaplastic thyroid carcinoma
    Rushton, Sarah
    Burghel, George
    Wallace, Andrew
    Nonaka, Daisuke
    HISTOPATHOLOGY, 2016, 69 (03) : 524 - 526
  • [39] BRAF and MEK Inhibitor Treatment for Metastatic Undifferentiated Sarcoma of the Spermatic Cord with BRAF V600E Mutation
    Saijo, Ken
    Imai, Hiroo
    Katayama, Hiromichi
    Fujishima, Fumiyoshi
    Nakamura, Kenichi
    Kasahara, Yuki
    Ouchi, Kota
    Komine, Keigo
    Shirota, Hidekazu
    Takahashi, Masanobu
    Ishioka, Chikashi
    CASE REPORTS IN ONCOLOGY, 2022, 15 (02): : 762 - 769
  • [40] BRAF V600E expression in histiocytic sarcoma associated with splenic marginal zone lymphoma: a case report
    Vaughn J.L.
    Freitag C.E.
    Hemminger J.A.
    Jones J.A.
    Journal of Medical Case Reports, 11 (1)
12345